Evidence map›Paper›PMID 37280207›Full record

ArticleBone research2023

Super enhancers targeting ZBTB16 in osteogenesis protect against osteoporosis.

Wenhui Yu, Zhongyu Xie, Jinteng Li, Jiajie Lin, Zepeng Su, Yunshu Che, Feng Ye, Zhaoqiang Zhang, Peitao Xu, Yipeng Zeng and 6 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Bone research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. [Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2023
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 1 institution in 1 country.

Wenhui Yu *Department of Orthopedics, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, 518003, PR China.
Zhongyu Xie *Department of Orthopedics, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, 518003, PR China.
Jinteng LiDepartment of Orthopedics, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, 518003, PR China.
Jiajie LinDepartment of Orthopedics, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, 518003, PR China.
Zepeng SuDepartment of Orthopedics, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, 518003, PR China.
Yunshu CheDepartment of Orthopedics, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, 518003, PR China.
Feng YeDepartment of Orthopedics, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, PR China.
Zhaoqiang ZhangDepartment of Orthopedics, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, 518003, PR China.
Peitao XuDepartment of Orthopedics, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, 518003, PR China.
Yipeng ZengDepartment of Orthopedics, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, 518003, PR China.
Xiaojun XuDepartment of Orthopedics, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, 518003, PR China.
Zhikun LiDepartment of Orthopedics, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, 518003, PR China.
Pei FengCenter for Biotherapy, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, 518003, PR China.
Rujia MiCenter for Biotherapy, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, 518003, PR China.
Yanfeng WuShenzhen Key Laboratory of Ankylosing Spondylitis, Shenzhen, 518003, PR China. wuyf@mail.sysu.edu.cn.
Huiyong ShenDepartment of Orthopedics, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, 518003, PR China. shenhuiy@mail.sysu.edu.cn.ORCID http://orcid.org/0000-0002-4317-3468
Sun Yat-sen University · CN

Funding

National Natural Science Foundation of China (National Science Foundation of China) 82172349National Natural Science Foundation of China (National Science Foundation of China) 82172385
6 · The paper itself

Abstract

As the major cell precursors in osteogenesis, mesenchymal stem cells (MSCs) are indispensable for bone homeostasis and development. However, the primary mechanisms regulating osteogenic differentiation are controversial. Composed of multiple constituent enhancers, super enhancers (SEs) are powerful cis-regulatory elements that identify genes that ensure sequential differentiation. The present study demonstrated that SEs were indispensable for MSC osteogenesis and involved in osteoporosis development. Through integrated analysis, we identified the most common SE-targeted and osteoporosis-related osteogenic gene, ZBTB16. ZBTB16, positively regulated by SEs, promoted MSC osteogenesis but was expressed at lower levels in osteoporosis. Mechanistically, SEs recruited bromodomain containing 4 (BRD4) at the site of ZBTB16, which then bound to RNA polymerase II-associated protein 2 (RPAP2) that transported RNA polymerase II (POL II) into the nucleus. The subsequent synergistic regulation of POL II carboxyterminal domain (CTD) phosphorylation by BRD4 and RPAP2 initiated ZBTB16 transcriptional elongation, which facilitated MSC osteogenesis via the key osteogenic transcription factor SP7. Bone-targeting ZBTB16 overexpression had a therapeutic effect on the decreased bone density and remodeling capacity of Brd4

Identifiers

PMID37280207
PMCPMC10244438
OpenAlexW4379600686

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.